← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2009Last known activity
Mar 1, 2015
Timeline
1990s
- Jan 1, 1999
Rafik Hariri University— Founded
Drugs by trial phase (5 distinct, 6 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Avitaminosis
- beta-Thalassemia
- Choroidal Neovascularization
- Diabetic Retinopathy
- Insulin Resistance
- Macular Degeneration
- Macular Edema
- Metabolic Diseases
- Neovascularization, Pathologic
- Osteoporosis
- Pterygium
- Retinal Diseases
- Retinal Neovascularization
- Retinal Vein Occlusion
- Rickets
- Thalassemia
- Uveitis
- Vitamin D Deficiency
Recent trials (8)
- NCT02486484Lead sponsorPhase 2Mar 1, 2015
- NCT02486484Reponsible party - principal investigatorPhase 2Mar 1, 2015
- NCT02173873Lead sponsorPhase 1Jun 1, 2014
- NCT02173873Reponsible party - principal investigatorPhase 1Jun 1, 2014
- NCT01642758Overall official - principal investigatorPhase 2May 1, 2012
- NCT01286909Overall official - principal investigatorPhase 3Jan 1, 2011
- NCT01315366CollaboratorPhase 3Jan 1, 2011
- NCT00855608Lead sponsorPhase 1Mar 1, 2009
Details
- Founded
- Mechref, LB Jan 1, 1999
- Last known activity
- Mar 1, 2015